# Novorex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novorex

- Industry: Pharmaceuticals
- Headquarters: Seongnam, South Korea
- Website: www.novorex.com
- Total disclosed funding: $23M
- Latest round: Series B (Apr 9, 2026)
- Investors on record: 14

## About

Founded in 2020 and based in Gyeonggi-do, South Korea, Novorex Inc. is focusing on new drug development to treat oncology and neurology diseases, particularly strengthens small-molecule new drugs using the three-dimensional structure of proteins and molecular calculations. In 2020, the company opened its Seoul Research Center and established corporate research institute. In 2021, its Jeongeup Branch and Pangyo Research Center were established and an application to be a military service exception company was filed. In April 2026, Novorex Inc. raised KRW 21 billion in series B funding from new investors Korea Development Bank, K & Investment Partners, Solidus Investment, SBI Investment Korea, and Hyundai Venture Investment. Returning investors KB Investment, AON Investment, and UTC Investment also participated in this round.

The company created drug development systems called Seamless Drug Discovery, Deep Designer, and Novo Picker.

The company will use the April 2026 funding to fund its global phase 1 clinical trials of its lead pipeline NRX-NGT002 which is a Parkinson's disease treatment targeting the LRRK2 protein.

## Funding rounds

- Series B, Apr 9, 2026, $14M — SBI Investment Korea, Korea Development Bank, Hyundai Venture Investment, KB Investment, Solidus Investment, UTC Investment, K & Investment Partners, AON Investment
- Series A, Jul 20, 2021, $9.1M — WOORI Venture Partners, Company K Partners, UTC Investment, BNH Investment, LS Securities, Synergy IB Investment
- Seed, Mar 1, 2020 — Korea Tech Incubator for Startup, Synergy IB Investment

## Investors

- Korea Tech Incubator for Startup — Seed
- Synergy IB Investment (https://capitalatlas.ai/funds/synergy-ib-investment) — Seed, Series A
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series A, Series B
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A
- LS Securities — Series A
- SBI Investment Korea (https://capitalatlas.ai/funds/sbi-investment-korea) — Series B
- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series B
- Hyundai Venture Investment (https://capitalatlas.ai/funds/hyundai-venture-investment) — Series B
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series B
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series B
- K & Investment Partners (https://capitalatlas.ai/funds/k-investment-partners) — Series B
- AON Investment (https://capitalatlas.ai/funds/aon-investment) — Series B